These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 22321971

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
    Ochnik AM, Moore NL, Jankovic-Karasoulos T, Bianco-Miotto T, Ryan NK, Thomas MR, Birrell SN, Butler LM, Tilley WD, Hickey TE.
    Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
    [Abstract] [Full Text] [Related]

  • 5. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, Belfiore A.
    Cancer Res; 2005 Mar 01; 65(5):1849-57. PubMed ID: 15753383
    [Abstract] [Full Text] [Related]

  • 6. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R, Robson CN, Shenton BK, Leung HY.
    J Cell Physiol; 2007 Sep 01; 212(3):572-8. PubMed ID: 17541959
    [Abstract] [Full Text] [Related]

  • 7. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
    Desiniotis A, Schäfer G, Klocker H, Eder IE.
    Int J Cancer; 2010 Feb 01; 126(3):775-89. PubMed ID: 19653278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F, Chiodo C, Morelli C, Casaburi I, Marsico S, Bruno R, Sisci D, Andò S, Lanzino M.
    BMC Cancer; 2019 Nov 04; 19(1):1038. PubMed ID: 31684907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly.
    Giovannelli P, Di Donato M, Auricchio F, Castoria G, Migliaccio A.
    Sci Rep; 2019 Mar 14; 9(1):4490. PubMed ID: 30872694
    [Abstract] [Full Text] [Related]

  • 14. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
    Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gómez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, Torkko KC, Thor AD, Elias AD, Protter AA, Richer JK.
    Breast Cancer Res; 2014 Jan 22; 16(1):R7. PubMed ID: 24451109
    [Abstract] [Full Text] [Related]

  • 15. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.
    Prostate; 2005 Dec 01; 65(4):287-98. PubMed ID: 16015608
    [Abstract] [Full Text] [Related]

  • 16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 17. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT, Wilson EM, Shapiro DJ.
    J Biol Chem; 2012 Jul 06; 287(28):23368-80. PubMed ID: 22589544
    [Abstract] [Full Text] [Related]

  • 18. The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells.
    Terakawa T, Miyake H, Kumano M, Sakai I, Fujisawa M.
    Oncol Rep; 2010 Nov 06; 24(5):1395-9. PubMed ID: 20878136
    [Abstract] [Full Text] [Related]

  • 19. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 20. Targeting androgen receptor in estrogen receptor-negative breast cancer.
    Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y, Rimm DL, Liu XS, Brown M.
    Cancer Cell; 2011 Jul 12; 20(1):119-31. PubMed ID: 21741601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.